Patents Assigned to Vaccinogen, Inc.
  • AUTOLOGOUS TUMOR VACCINES AND METHODS
    Publication number: 20180008686
    Abstract: Autologous anti-cancer vaccines and methods of manufacture and treatment are provided, including expansion of individual patient-derived tumor cells in an immune-compromised animal(s) to attain, quantitatively and qualitatively, sufficient material for efficacious vaccine production and utilization, to elicit an immune response against micrometastases and/or recurrence in the individual patient following tumor excision.
    Type: Application
    Filed: February 22, 2017
    Publication date: January 11, 2018
    Applicant: Vaccinogen, Inc.
    Inventor: Michael G. Hanna, JR.
  • ADENOCARCINOMA ANTIGENIC DETERMINANTS AND METHODS
    Publication number: 20170226171
    Abstract: Adenocarcinoma antigenic determinants, methods for their production and use, and broadly-specific human monoclonal antibodies reactive to the epitopes. These epitopes, which can be physically recapitulated, are conserved across a range of adenocarcinomas and are capable of eliciting an immune response in humans.
    Type: Application
    Filed: April 4, 2016
    Publication date: August 10, 2017
    Applicant: Vaccinogen, Inc.
    Inventors: Michael George Hanna, JR., Jason David Howard